Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Monthly oral methylprednisolone pulse treatment in progressive multiple sclerosis.
α-Synuclein deficiency promotes neuroinflammation by increasing Th1 cell-mediated immune responses.
In Vivo Visualization of (Auto)Immune Processes in the Central Nervous System of Rodents.
Differential expression of glucose-metabolizing enzymes in multiple sclerosis lesions.
Editorial Comments: Is multiple sclerosis a neurodegenerative or inflammatory disease?
Medical image. Neuromyelitis optica masquerading as sepsis.
Neuregulin/ErbB Signaling in Developmental Myelin Formation and Nerve Repair.
Reply to the Comment by Yolcu et al. on Our Paper Entitled ´Evaluation of Choroidal Vascular Changes in Patients with Multiple Sclerosis Using Enhanced Depth Imaging Optical Coherence Tomography´.
Gray Matter Volume Reduction Is Associated with Cognitive Impairment in Neuromyelitis Optica.
Lymphocytic hypophysitis associated with pediatric multiple sclerosis.
Functional course of Progressive Multifocal Leukoencephalopathy.
Laquinimod therapy in multiple sclerosis: a comprehensive review.
The Effect of Plasma Exchange on the Expression of FOXP3 and RORC2 in Relapsed Multiple Sclerosis Patients.
Co-morbidities increase the risk of disability pension among MS patients: a population-based nationwide cohort study.
Attributions and self-efficacy for physical activity in multiple sclerosis.
Efficacy of subcutaneous interferon β-1a on MRI outcomes in a randomised controlled trial of patients with clinically isolated syndromes.
Effect of intrahippocampal administration of vitamin C and progesterone on learning in a model of multiple sclerosis in rats.
CD24 gene allele variation is not associated with oligoclonal IgG bands and IgG index of multiple sclerosis patients.
Hypomyelination following deletion of Tsc2 in oligodendrocyte precursors.
TLR3 Agonist Poly-IC Induces IL-33 and Promotes Myelin Repair.
Multiple sclerosis and neurofibromatosis type 1: report of seven patients from Iran.
An atypical case of acute disseminated encephalomyelitis associated with cytomegalovirus infection.
Serum NSE and multiple sclerosis.
Evaluator-blinded trial evaluating nurse-led immunotherapy DEcision Coaching In persons with relapsing-remitting Multiple Sclerosis (DECIMS) and accompanying process evaluation: study protocol for a cluster randomised controlled trial.
Relation of Posterior Cerebellar Volume to Cognition in MS.
Pages
« first
‹ previous
…
645
646
647
648
649
650
651
652
653
…
next ›
last »